4//SEC Filing
Levine James E. 4
Accession 0001610618-21-000024
CIK 0001610618other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 9:12 PM ET
Size
6.9 KB
Accession
0001610618-21-000024
Insider Transaction Report
Form 4
Levine James E.
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2021-03-17+130,000→ 130,000 totalExercise: $2.55Exp: 2031-03-16→ Common Stock (130,000 underlying)
Holdings
- 69,803
Common Stock
- 50,000(indirect: By Spouse)
Common Stock
Footnotes (2)
- [F1]Includes 3,969 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on November 20, 2020.
- [F2]The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 17, 2021.
Documents
Issuer
Cidara Therapeutics, Inc.
CIK 0001610618
Entity typeother
Related Parties
1- filerCIK 0001463151
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 9:12 PM ET
- Size
- 6.9 KB